Latest HMPV News | Top HMPV News Headlines Today | Today India news | Breaking HMPV News Today | English HMPV News Headlines - TheDailyGuardian

HMPV Cases Surge in India: Over 15 Infections Reported Across States

January 14, 2025, 7:19 pm

Human metapneumovirus (HMPV) has been found in more than 15 cases in different parts of India this season. Health authorities are concerned about the situation. As the virus spreads, experts recommend preventive measures and urge people to be vigilant.

Cases Reported in Multiple States

The cases of HMPV have gradually increased over the last one year in India. Cases have been reported from three places in Puducherry and five places in Gujarat. Assam has reported its first case of this season on Monday. Even though the HMPV is not a new virus, the increasing reports in India of this virus are grabbing attention in this season.

What is HMPV?

HMPV is a respiratory virus, and the infection has resulted in a number of symptoms that are like those of the common viral infections, which include flu and influenza. The infected patients complain of cough, fever, sore throat, running nose, body aches, and headaches. Due to overlapping symptoms, HMPV infection is challenging to diagnose. The health care providers usually treat the patient based on the symptoms, not the tests for the specific virus.

Preventive Measures for HMPV Infection

To reduce the risk of infection, health organizations, including the WHO, recommend a few precautions. These include wearing a mask while venturing out, washing hands often, and a healthy balanced diet. Since HMPV does not have a specific medication, doctors prescribe symptomatic treatment, which may be in the form of over-the-counter medicines and inhalers.

HMPV Global Update

The rate of infections with HMPV has reduced in the north in China, and scientists have said that the virus is not a new threat and has existed in humans for decades. In a press conference, Wang Liping, an investigator at China’s Center for Disease Control and Prevention, emphasized that the cases were under control, and that on respiratory diseases like HMPV, China communicates closely with WHO.

Experts point out that with the rising cases of HMPV all over the world, including in India, precautions need to be taken by everyone to avoid catching the infection. The virus itself is not as virulent; good hygiene practice and avoiding congested places will help decrease the spread of the virus.

HMPV: 10-Month-Old Tests Positive in Assam’s Dibrugarh; India Records 10 Cases So Far

January 11, 2025, 12:30 pm

A 10-month-old baby in Assam’s Dibrugarh has been diagnosed with Human Metapneumovirus. It is the first reported case of the year for the state, officials said.

The child was admitted to Assam Medical College and Hospital (AMCH) for a common cold, and the infection was detected during routine HMPV screening at the Regional VRDL laboratory under ICMR-RMRC. Although the laboratory has identified over 100 cases of HMPV in Dibrugarh since 2014, this is the first case of 2025.

Assam Health Minister Ashok Singhal said that HMPV was not a new virus and the government in state is prepared to follow central advisories for necessary measures.

AMCH Superintendent Dhrubajyoti Bhuyan added more info about the issue, saying “Four days ago, the child was admitted at AMCH for a common cold case. Yesterday only, the kid was found suffering from the infection after a sample test from Lahowal ICMR-RMRC,” he added also mentioning that his condition is stabilized and said: “It’s a common bug that affects infants till five, and there’s nothing to frown upon.

India’s Increasing HMPV Cases

Since January 7, India has reported at least 10 HMPV infections. The first cases were reported in Karnataka and Tamil Nadu, followed by confirmations in Gujarat, Nagpur, Mumbai, and Ahmedabad. In total, confirmed cases include two in Bengaluru, one in Gujarat, two in Chennai, three in Kolkata, two in Nagpur, and one in Mumbai.

HMPV infections are not new to India. Cases were reported in December also. Union Health Minister JP Nadda clarified that the virus was first identified in 2001 and has been circulating globally for years.

HMPV Strikes Back: New Strains Elevate Risks for Kids’ Health

January 9, 2025, 1:14 pm

Respiratory illnesses are a significant concern for pediatric health worldwide, with many viruses contributing to the distressing symptoms children experience. One such virus, Human Metapneumovirus (HMPV), has emerged as a major cause of respiratory distress, particularly in younger children, infants, and those with compromised immune systems. HMPV shares many similarities with other respiratory viruses, such as Respiratory Syncytial Virus (RSV) and Influenza, and is known to cause a range of mild to severe respiratory symptoms.

In recent years, there has been growing concern about the evolving strains of HMPV, particularly strains A2.2.1 and A2.2.2, which have shown evidence of increased transmission rates and a potential for more severe infections. This article delves into the latest findings about HMPV’s impact on pediatric health, explores the evolving nature of the virus, and offers insights into how these changes could affect the management and prevention of respiratory distress in children.

Understanding Human Metapneumovirus (HMPV)

Human Metapneumovirus (HMPV) is a viral pathogen belonging to the Metapneumovirus genus in the Pneumoviridae family. First identified in 2001, HMPV has since been recognized as one of the leading causes of respiratory infections in children, similar to other common viruses like RSV and the flu. The virus is highly contagious and primarily affects the respiratory system, causing symptoms ranging from mild cold-like signs to severe respiratory distress, particularly in infants, the elderly, and those with underlying health conditions.

The virus is transmitted through respiratory droplets when an infected person coughs or sneezes, or via contaminated surfaces. As with many respiratory viruses, close contact with infected individuals, especially in crowded settings such as daycares and schools, increases the likelihood of transmission.

Symptoms of HMPV Infection

The symptoms of HMPV infection can vary widely depending on the severity of the infection and the age of the affected individual. In many cases, the symptoms are mild and may resemble those of the common cold, including:

Runny or stuffy nose
Cough
Low-grade fever
Sore throat
Mild fatigue

However, in more severe cases, particularly among young children and those with weakened immune systems, HMPV can cause more serious respiratory symptoms, such as:

Wheezing
Shortness of breath
Rapid or labored breathing
Chest tightness
Pneumonia
Bronchiolitis (inflammation of the small airways in the lungs)

The severity of the infection can vary based on the child’s age, overall health, and immune system function. Infants under the age of two, premature infants, and children with pre-existing respiratory conditions like asthma or cystic fibrosis are at higher risk for developing severe respiratory complications from HMPV infection.

Impact of HMPV on Pediatric Health

HMPV infections in children have garnered significant attention due to the range of symptoms that can result in severe illness. In particular, HMPV is associated with an increased risk of hospitalization, particularly for infants and young children. Studies show that HMPV is a significant cause of respiratory distress, accounting for a large proportion of admissions to pediatric intensive care units (ICUs) during peak seasons.

Respiratory distress resulting from HMPV can have long-term consequences for children, especially those with underlying conditions. Chronic lung disease, prolonged wheezing, and increased susceptibility to future respiratory infections can persist after an acute HMPV infection, placing a strain on both the child’s health and the healthcare system.

The Emergence of New Strains: A2.2.1 and A2.2.2

One of the most concerning aspects of HMPV is its ability to evolve and develop new strains over time. New research has highlighted the rise of strains A2.2.1 and A2.2.2, which are demonstrating the virus’s increasing genetic diversity. These emerging strains have raised alarms due to their potential for increased transmissibility and severity.

Strains A2.2.1 and A2.2.2 are part of the larger A2 clade, a genetically distinct group of HMPV variants that has been circulating in recent years. Genetic analysis shows that these new strains exhibit mutations in key areas of the virus’s genome, which may influence how the virus interacts with the host’s immune system, leading to higher rates of infection and possibly more severe illness.

Why Are These Strains Concerning?

The mutations seen in strains A2.2.1 and A2.2.2 could make the virus more adept at evading the body’s immune response, making it more difficult for the immune system to mount an effective defense. This raises concerns about how these new strains may impact the effectiveness of existing vaccines, treatments, and public health measures. Additionally, these new strains could lead to a higher incidence of severe disease, particularly among vulnerable populations such as children and the elderly.

Increased Transmission Rates

One of the primary concerns with these new strains is their potential to spread more easily than previous versions of HMPV. Increased transmission could result in higher case numbers, which in turn could place more pressure on healthcare systems already grappling with other respiratory viruses like RSV and influenza. The emergence of new strains often signals that the virus is adapting to better infect and spread among the population.

Evasion of Immunity

Another major concern is the potential for these strains to evade immunity from previous infections or vaccinations. This is particularly important for children who have previously been exposed to HMPV, as their immune system may not recognize the new strains as effectively. This phenomenon is common among respiratory viruses, which tend to evolve rapidly, leading to the emergence of new variants that can bypass previous immune protections.

Current Measures to Address HMPV and Emerging Strains

Given the rising concerns over the evolving strains of HMPV, several measures are being taken to mitigate the impact of the virus, particularly in pediatric populations.

Surveillance and Monitoring: Ongoing genetic surveillance is critical to track the emergence and spread of new strains, such as A2.2.1 and A2.2.2. Researchers and healthcare professionals are working together to monitor the genetic makeup of HMPV strains circulating in the population, providing valuable insights into how the virus is evolving and which populations are most at risk.
Prevention and Hygiene: As with other respiratory viruses, the spread of HMPV can be minimized by practicing good hygiene. Handwashing, avoiding close contact with sick individuals, and disinfecting frequently touched surfaces can help reduce the risk of transmission. In addition, avoiding large crowds and public spaces, especially during peak infection seasons, can also help curb the spread of HMPV.
Vaccines and Treatments: Although there is currently no specific vaccine for HMPV, researchers are actively working on developing one. Vaccine candidates are being tested to address the various strains of HMPV, including the newer, more concerning strains like A2.2.1 and A2.2.2. In the meantime, supportive treatments are being used to manage symptoms of HMPV infections, such as fever, cough, and difficulty breathing.
Hospital and ICU Preparedness: Hospitals are preparing for potential surges in pediatric respiratory distress due to HMPV and other viruses. Intensive care units (ICUs) are on high alert, with a focus on providing respiratory support for children suffering from severe infections. Mechanisms to expedite testing and ensure timely treatment are also critical in managing cases effectively.

The Evolving Threat of HMPV

HMPV has proven to be a significant cause of respiratory illness, particularly among children. The emergence of new strains, such as A2.2.1 and A2.2.2, highlights the evolving nature of the virus and its potential to pose an even greater threat to public health. As the virus continues to evolve, healthcare professionals must stay vigilant in tracking new strains and adapting treatment and prevention strategies to mitigate the impact of HMPV infections.

For parents, caregivers, and healthcare providers, understanding the symptoms, transmission methods, and potential risks of HMPV is key to managing this threat. While more research is needed to fully understand the long-term implications of these new strains, the focus remains on early detection, prevention, and the development of effective vaccines and treatments.

With careful monitoring, improved hygiene practices, and ongoing research, we can work towards minimizing the impact of HMPV and its evolving strains on children and vulnerable populations worldwide.

US Faces HMPV Surge as Doctors Warn of Severe Flu Season; CDC Monitors China Situation

January 7, 2025, 4:00 pm

As new data suggests a rise in HMPV cases in the US, experts are calling for greater transparency from China regarding an influenza outbreak overwhelming its hospitals. China claims that respiratory illnesses are “less severe” and “smaller in scale” compared to 2024, attempting to downplay the viral images circulating on social media of crowded wards and waiting areas.

These images have sparked concerns that the spread of the relatively unknown human metapneumovirus (HMPV) in China may echo the early stages of the 2019 COVID outbreak, which was initially reported in the country. The symptoms of HMPV include cold-like signs such as headaches, chills, fatigue, and congestion.

Dr. Sanjaya Senanayake, an infectious diseases expert at the Australian National University, emphasized the importance of China sharing data about the outbreak in a timely manner. This includes information on who is being infected, along with genetic data to confirm HMPV as the culprit and determine whether any concerning mutations have emerged. Such data would also aid in the development of vaccines, Senanayake noted.

In the US, the number of HMPV cases has surged, with test positivity rates doubling from the beginning to the end of December. The CDC reported that fewer than 300 positive results were recorded during the final week of December. Although the CDC is “monitoring” the situation in China, it has stated that the current cases in the US “are not currently a cause for concern.”

Dr. Andrew Catchpole, chief scientific officer at infectious disease biotech company hVIVO, noted that HMPV typically peaks in winter in several countries. However, he observed that “rates of serious infection may be higher in China than what we would expect in a normal year.” According to the CDC’s National Respiratory and Enteric Virus Surveillance System (NREVSS), HMPV cases in the US have surpassed last year’s numbers. In the last week of December, the positivity rate stood at 1.9%, with 300 confirmed cases out of 13,800 tests.

Is HMPV The Next Pandemic? Here Is Experts Say About It

January 7, 2025, 12:08 pm

Health experts have eased concerns surrounding Human Metapneumovirus (HMPV), emphasising that it is not as contagious as COVID-19. Unlike COVID-19, which had an unknown origin before its emergence, HMPV has been documented since the 1950s. According to Dr. Vishal Rao, a Surgical Oncologist, HMPV spreads via respiratory droplets rather than airborne or verbal transmission. He urged the public not to panic and assured that those vaccinated with a flu shot and three doses of the COVID-19 vaccine likely have some level of immunity against the virus.

No Vaccine Yet, But Precautions Help

Currently, there is no specific vaccine available for HMPV. However, Dr. Rao highlighted that basic precautions are crucial to prevent infection. “HMPV does not spread through talking or breathing like COVID-19. It’s a droplet infection caused by coughing, so maintaining good hygiene is essential,” he explained. Individuals can protect themselves by wearing masks, washing hands regularly, and avoiding close contact with symptomatic individuals.

HMPV: A Well-Documented Virus

Dr. Neeraj Nischal, an Additional Professor of Internal Medicine at AIIMS Delhi, explained that HMPV should not be compared to COVID-19. “COVID-19 was a completely new virus, whereas HMPV has been described since 2001 and traced back to the late 1950s. By the age of 10, most children develop immunity against it,” he noted. India has reported three confirmed cases of HMPV, two in Karnataka and one in Gujarat, but officials have reassured the public that there is no cause for alarm.

Severe Cases and Brain Inflammation

While HMPV usually causes mild symptoms like fever, cough, and nasal congestion, it can lead to serious complications in vulnerable individuals. Dr. Praveen Gupta, Principal Director and Chief of Neurology at Fortis Hospital, cautioned that the virus could trigger immune-mediated encephalitis, leading to brain inflammation. “This can result in symptoms such as fever, vomiting, seizures, and paralysis. Diagnosis involves an MRI, EEG, or cerebrospinal fluid (CSF) examination, and treatment includes medications to manage brain pressure and immune responses,” he explained.

Preventive Measures

Experts emphasized adopting precautions similar to those for other respiratory illnesses like RSV and influenza:

Wear a mask when symptomatic or in crowded places.
Practice good hand hygiene, including regular hand washing with soap.
Avoid close contact with infected individuals.
Cover your mouth and nose when coughing or sneezing.
Disinfect surfaces frequently touched by others.

Symptoms and At-Risk Groups

Dr. Mahua Kapoor Dasgupta, Director of Medical Affairs (Infectious Diseases) at Haystack Analytics, explained that HMPV belongs to the Paramyxoviridae family, which includes the Respiratory Syncytial Virus (RSV). It typically affects both the upper and lower respiratory tracts, with severe cases leading to bronchiolitis or pneumonia in high-risk populations such as children under five, elderly individuals, and immunocompromised patients. Common symptoms include fever, cough, nasal congestion, and shortness of breath.

Treatment and Home Care

Treatment for HMPV generally involves supportive care at home, including rest, hydration, and over-the-counter medications like antipyretics and nasal decongestants. In cases of secondary bacterial infections, antibiotics may be prescribed. For critically ill patients, hospital care may be necessary to manage complications.

Flu Season and HMPV Awareness

Dr. Sandeep Budhiraja, Group Medical Director at Max Healthcare, noted that HMPV is one of several respiratory viruses active during the flu season. “These viruses, including influenza and adenoviruses, cause similar symptoms like fever, headache, and nasal congestion. Most cases are mild, but complications can arise in vulnerable groups,” he said. He also highlighted the lack of a specific vaccine or treatment for HMPV, despite decades of research.

Experts reassured the public that while HMPV is not new, awareness and preventive measures are key to controlling its spread. By following hygiene protocols and seeking timely medical advice, individuals can effectively safeguard themselves and others from the virus.

HMPV: Is it a Harbinger of COVID 19 ? Causes and Cure

January 7, 2025, 12:25 am

The Chinese Center for Disease Control and Prevention published data showing that respiratory infections had risen significantly in the week of December 16 to 22, 2024; human metapneumovirus was linked to 6.2 percent of positive respiratory illness tests and 5.4 percent of respiratory-illness hospitalizations in China, more than COVID-19, rhinovirus or adenovirus. Kan Biao, head of the China CDC’s National Institute for Communicable Disease Control and Prevention, announced that the rate of HMPV among children ages 14 and under was on the rise in China. Countries like Malaysia, Hong Kong, and India have also confirmed cases of HMPV infection.

Human metapneumovirus is an important respiratory pathogen that was first discovered in 2001 by researchers at the Erasmus Medical Center in the Netherlands. Despite being relatively new in the context of human viruses, HMPV has become recognized as a significant cause of respiratory illness, especially in young children, the elderly, and immunocompromised individuals. This virus is part of the Pneumoviridae family, which also includes respiratory syncytial virus (RSV), another well-known cause of respiratory infections.

Virology

HMPV is an enveloped, single-stranded, negative-sense RNA virus. It shares structural and functional similarities with RSV, as both viruses belong to the same family. The virus has a lipid bilayer envelope that contains glycoproteins, including the fusion (F) protein and the attachment (G) protein. These proteins play crucial roles in the virus’s ability to infect host cells by facilitating the binding of the virus to cell receptors and enabling viral fusion with the host cell membrane.

The genome of HMPV is approximately 13,000 nucleotides long and encodes for several proteins that are involved in replication and the formation of the virus’s structure. The F protein is critical for viral entry into cells by mediating the fusion of the viral and host cell membranes. The G protein, on the other hand, is primarily responsible for viral attachment to host cells and is considered a key target for immune responses. Other proteins encoded by the virus include the matrix (M) protein, which aids in the assembly of new virions, and the non-structural (NS) proteins, which play a role in modulating the host’s immune response.

Transmission

HMPV is primarily transmitted through respiratory droplets, making close contact with infected individuals a primary route of spread. It can also be transmitted by touching surfaces contaminated with the virus and then touching the face, especially the eyes, nose, or mouth. The virus infects the upper and lower respiratory tract, causing symptoms that range from mild cold-like symptoms to severe respiratory distress.

HMPV infections are most common during the colder months, typically from winter to early spring, similar to other respiratory viruses such as RSV and influenza. The virus is ubiquitous worldwide, and infections occur in both developed and developing countries. Although HMPV can infect people of all ages, it is most frequently seen in children under five years of age, the elderly, and individuals with underlying health conditions such as asthma, chronic obstructive pulmonary disease (COPD), or immunodeficiency. It has also been associated with severe disease in organ transplant recipients and those with compromised immune systems.

The incidence of HMPV infection is difficult to determine accurately because the virus often causes mild symptoms that can be mistaken for a common cold or other respiratory infections. However, studies have shown that HMPV is a major cause of bronchiolitis and pneumonia in young children and is often detected in children hospitalized with respiratory illnesses.

Clinical Manifestations

The clinical presentation of HMPV infection can vary widely, ranging from mild upper respiratory symptoms to severe lower respiratory tract disease. In general, HMPV causes an illness similar to that of RSV and influenza, including symptoms such as: cough, runny nose, fever, sore throat, wheezing, and shortness of breat.

In infants and young children, HMPV infection can lead to bronchiolitis or pneumonia, both of which are characterized by inflammation and congestion in the airways and the lungs. The symptoms in these cases can be severe and may require hospitalization. Pneumonia caused by HMPV may present with fever, cough, difficulty breathing, and crackling sounds in the lungs.

In immunecompromised patients, such as organ transplant recipients or those undergoing chemotherapy, HMPV infection can be more severe and potentially life-threatening. These patients may experience prolonged symptoms and increased risks of complications like secondary bacterial infections or respiratory failure. In the elderly, the virus can also cause significant morbidity and mortality, particularly in those with pre-existing lung or heart conditions.

Diagnosis

Diagnosing HMPV infections can be challenging due to its similarity in clinical presentation to other respiratory viruses like RSV, influenza, and rhinovirus. The gold standard for diagnosing HMPV is the detection of the virus through laboratory methods, such as polymerase chain reaction (PCR) assays, which can identify the viral RNA in respiratory samples like nasal swabs, throat swabs, or bronchoalveolar lavage fluid.

Other diagnostic methods include viral culture and direct immunofluorescence, but these techniques are less commonly used due to their longer processing times and lower sensitivity compared to PCR. Serological tests, which detect antibodies against HMPV, can be useful for understanding past infections, but they are not typically used for acute diagnosis.

Treatment

There is currently no specific antiviral treatment available for HMPV infections. Management of the infection is largely supportive, aimed at alleviating symptoms and preventing complications. For mild cases, treatment focuses on symptomatic relief, such as:

Hydration

Antipyretics (fever-reducing medications like acetaminophen or ibuprofen)

Saline nasal sprays or suctioning to clear nasal congestion

Cough suppressants (if appropriate)

In more severe cases, such as those involving bronchiolitis or pneumonia, hospitalization may be required. Supportive care may include supplemental oxygen, mechanical ventilation, or respiratory support through non-invasive positive pressure ventilation (NIPPV) if the patient has difficulty breathing.

For individuals with underlying health conditions, careful monitoring and more aggressive interventions may be necessary. In immunocompromised individuals, antiviral medications such as ribavirin have been studied, though their efficacy specifically for HMPV remains uncertain. However, ribavirin is not routinely recommended as a treatment for HMPV.

Prevention

Preventing HMPV infection involves reducing the spread of the virus, particularly in settings where individuals at high risk of severe disease, such as young children and the elderly, are present. Standard preventive measures include:

Frequent handwashing

Avoiding close contact with infected individuals

Covering the mouth and nose when coughing or sneezing

Disinfecting commonly touched surfaces

For individuals at high risk, particularly those with chronic respiratory conditions or weakened immune systems, avoiding crowded places during peak respiratory virus seasons and seeking medical advice at the onset of symptoms can help minimize the risk of severe disease.

Vaccines for HMPV are not yet available, although research is ongoing. Given the similarity of HMPV to RSV, there is hope that advances in RSV vaccine development may also provide insights into HMPV vaccine development in the future.

Future Directions and Research

Despite the recognition of HMPV as an important respiratory pathogen, much remains to be understood about the virus, particularly in terms of pathogenesis, immune responses, and vaccine development. Research efforts are focusing on studying how HMPV replicates within the host and the role of the various viral proteins can provide potential targets for antiviral therapies. Investigating how the immune system responds to HMPV, including the role of innate immunity, adaptive immunity, and potential immune evasion mechanisms, is crucial for developing more effective vaccines and treatments. Given the similarities between HMPV and RSV, there is ongoing research into developing vaccines that can protect against both viruses. Advances in RSV vaccine development may offer hope for an HMPV vaccine as well. As HMPV is often clinically indistinguishable from other respiratory infections, improving diagnostic methods for rapid and accurate detection of HMPV remains an important area of research.

No Patients Infected with HMPV in Mumbai, Says BMC

January 6, 2025, 7:43 pm

The Brihanmumbai Municipal Corporation (BMC) announced on Monday that no cases of Human Metapneumovirus (HMPV) have been reported in Mumbai and urged citizens to take necessary precautions.

“Various news has been published in the media regarding the ongoing outbreak of the Human Metapneumovirus (HMPV) virus in China. The Directorate of Health Services, Pune has issued a guideline in this regard on January 3, 2025. Information about what to do and what not to do has been given through the guidelines. The information is being given through the Public Health Department of the Brihanmumbai Municipal Corporation that no such patient infected with Human Metapneumovirus (HMPV) has been found in Mumbai city and suburbs. However, the Brihanmumbai Municipal Corporation administration is also appealing to citizens to follow the guidelines,” the BMC stated.

“It is a seasonal disease that usually occurs in winter and early summer, like RSV and flu. The virus was first detected in the Netherlands in the year 2001. There is no cause for concern regarding the report of Human Metapneumovirus virus detected in China. Necessary precautions are being taken in this regard and there is no need to create an atmosphere of unnecessary panic,” the BMC added.

As part of preventive measures, the health department advised citizens to cover their mouth and nose with a handkerchief or tissue when coughing or sneezing.
“Wash your hands frequently with soap and water or alcohol-based sanitizer. Stay away from public places if you have fever, cough and sneeze. Drink plenty of water and eat nutritious food. Ensure that there is adequate ventilation in all places to reduce transmission,” the BMC noted.

The department also urged people to avoid shaking hands, reusing tissues or handkerchiefs, and engaging in practices such as spitting in public places. “Close contact with sick people. Touching your eyes, nose and mouth frequently. Spitting in public places. Taking medicine (self-medication) without consulting a doctor,” it stated.

Meanwhile, the Indian Council of Medical Research (ICMR) earlier confirmed the detection of two HMPV cases in Karnataka through routine surveillance for respiratory pathogens.

Karnataka Chief Minister Siddaramaiah commented on the situation, saying, “It has been found in two children. I talked to Dinesh Gundurao who is in charge of the health department… He took up a meeting with the department. Whatever decision it takes, the government will implement it. The government will take all precautionary measures and document this disease…”

The Ministry of Health emphasized that these cases were identified as part of ICMR’s efforts to monitor and control respiratory illnesses across India. While HMPV is a common respiratory virus circulating globally, there has been no unusual surge in cases in the country.

The first case involves a 3-month-old female infant diagnosed with HMPV at Baptist Hospital in Bengaluru. She had a history of bronchopneumonia and was discharged after receiving treatment.

The second case was an 8-month-old male infant, also admitted to Baptist Hospital in Bengaluru with a similar history of bronchopneumonia. He tested positive for HMPV on January 3, 2025.

Despite the detections, the ICMR noted there has been no significant increase in Influenza-Like Illness (ILI) or Severe Acute Respiratory Illness (SARI) cases across the country.

HMPV: A Known Virus, Present Globally Since 2001

January 6, 2025, 6:17 pm

Human Metapneumovirus (HMPV), a globally recognized respiratory virus, recently gained attention following an outbreak reported in China.

In Karnataka, two cases of HMPV were recently detected as part of routine surveillance by the Indian Council of Medical Research (ICMR).

HMPV: What is it?

Human Metapneumovirus (HMPV) is a respiratory virus that affects people of all ages. First discovered in 2001, HMPV belongs to the Paramyxoviridae family and is closely related to Respiratory Syncytial Virus (RSV). It spreads primarily through respiratory droplets from coughing or sneezing and by touching contaminated surfaces or direct contact with infected individuals.

HMPV can cause a range of illnesses, from mild respiratory discomfort to severe complications, especially in vulnerable groups such as infants, elderly individuals, and those with weakened immune systems. Globally prevalent, HMPV tends to peak in temperate regions during late winter and early spring, although it circulates year-round in some areas.

Symptoms of HMPV

The symptoms of HMPV vary depending on age, overall health, and immune response. Mild cases typically present with symptoms similar to the common cold, such as a runny nose, sore throat, cough, and fever. Moderate symptoms may include a persistent cough, wheezing, and fatigue.

In severe cases, especially among high-risk groups, HMPV can lead to complications like bronchitis, bronchiolitis, pneumonia, or Severe Acute Respiratory Illness (SARI) requiring hospitalization.

Transmission and Prevention

HMPV spreads like other respiratory viruses, such as RSV and influenza, mainly through respiratory droplets or contact with contaminated surfaces. Preventive measures include:

Practicing good hand hygiene by washing hands frequently with soap and water
Covering the mouth and nose when sneezing or coughing
Wearing masks in crowded spaces
Avoiding close contact with infected individuals
Disinfecting frequently touched surfaces

Duration of HMPV

Mild cases of HMPV typically last a few days to a week, though lingering symptoms, like a cough, may persist longer. Severe cases may take longer to recover.

Diagnosis

HMPV can be difficult to diagnose based solely on symptoms, as it resembles other respiratory infections such as RSV and influenza. The gold standard for diagnosis is Reverse Transcription Polymerase Chain Reaction (RT-PCR), which detects HMPV RNA. Antigen detection assays offer quicker results.

In India, agencies like the Indian Council of Medical Research (ICMR) and the Integrated Disease Surveillance Programme (IDSP) monitor respiratory viruses, including HMPV, through surveillance systems.

Treatment

There is no specific antiviral treatment or vaccine for HMPV. Treatment is supportive and based on the severity of the infection:

Mild cases: Rest, hydration, and over-the-counter medications to manage fever and congestion.
Severe cases: Hospitalization, oxygen therapy, or mechanical ventilation may be needed for respiratory distress.

While research is ongoing for antiviral therapies and vaccines, early medical intervention and preventive measures remain crucial in managing HMPV infections.

Global and National Monitoring

HMPV has been reported globally, and in India, surveillance programs like ICMR and IDSP track respiratory illnesses, including HMPV. The government has reinforced its health infrastructure to detect and respond to emerging threats.

Similarities and Differences Between HMPV and COVID-19

While both HMPV and COVID-19 are respiratory viruses, they differ in key aspects:

Similarities: Both spread via respiratory droplets, direct contact, and contaminated surfaces. They can cause similar symptoms, including cough, fever, and difficulty breathing, and are particularly dangerous to vulnerable populations.
Differences: COVID-19, caused by the SARS-CoV-2 virus, has a broader range of symptoms, including loss of taste and smell, and can lead to severe complications like blood clots and multi-organ failure. Vaccines and antiviral treatments are available for COVID-19, while HMPV is managed with supportive care and lacks specific antiviral medications or vaccines.

HMPV Alert: Experts’ Advice About the Rising Respiratory Threat

January 6, 2025, 5:44 pm

In a recent announcement, the Health Ministry of India confirmed two cases of Human Metapneumovirus (HMPV) in Bengaluru, Karnataka has raised alarms among the public, especially with a rising number of respiratory infections. An eight-month-old who is recovering in the hospital and a three-month-old who has been discharged are the first reported cases of HMPV in India. This has led to growing concerns as the virus has been circulating globally. Despite the heightened awareness, health experts have reassured the public that while HMPV is contagious and flu-like, it is not a new or exceptionally dangerous virus. However, vulnerable populations, including young children, the elderly, and immunocompromised individuals, need to be particularly cautious.

What Is HMPV?

Human Metapneumovirus (HMPV), identified for the first time in 2001, is a respiratory virus that causes flu-like symptoms. It spreads primarily through direct contact, including coughing, sneezing, or touching contaminated surfaces. The symptoms of HMPV are quite similar to those of the common cold and flu, including cough, fever, sore throat, and nasal congestion. However, it can cause more severe respiratory issues in some cases, particularly in vulnerable individuals. The virus typically affects the upper and lower respiratory tracts and can lead to conditions like pneumonia or bronchiolitis. Although fatal cases are rare, the severity of illness can vary depending on a person’s health status.

Expert Advice from Healthcare Professionals

Several leading healthcare professionals have spoken out about the current scenario to provide clarity and expert advice. Dr. Sivaranjani Santosh, a Pediatrician at Magna Centres for Obesity, Diabetes, and Endocrinology at Film Nagar, Hyderabad. She has been treating HMPV patients since 2022 and provided some important insights on how the virus operates and how people should respond. Dr. Santosh emphasized that while the virus is circulating more widely at present, it is not new. She pointed out that HMPV is a regular feature of the respiratory virus landscape and has been known to cause illnesses on an annual basis.

Dr. Santosh stressed that there is no immediate cause for panic and that the virus’s presence in India should be taken in stride. However, she also pointed out the importance of vigilance, particularly in light of concerns about possible mutations. She explained, “If there are new mutations of HMPV, there is no data yet to suggest they would lead to more severe disease, but we must remain cautious.”

According to Dr. Santosh, most cases of HMPV are mild, and treatment generally involves supportive care, such as rest, hydration, and over-the-counter medications for fever and congestion. She also emphasized the need for public education on preventing the spread of respiratory viruses. “People should be educated on the importance of hygiene, avoiding close contact with sick individuals, and maintaining good respiratory hygiene, such as covering the mouth when coughing or sneezing,” she noted.

Symptoms of HMPV

HMPV manifests through several symptoms, which usually appear 3 to 6 days after exposure to the virus. The common symptoms include:

Cough
Fever
Sore throat
Nasal congestion
Shortness of breath

While many individuals experience mild symptoms, severe illness can occur, especially in those with weakened immune systems, such as young children (under 5 years), older adults, and those with pre-existing respiratory conditions. Hospitalization may be required for those who develop severe respiratory symptoms, including wheezing and significant difficulty breathing.

Transmission of HMPV

HMPV spreads easily from person to person. The virus can be transmitted through:

Direct contact: Shaking hands or touching surfaces contaminated with respiratory droplets from an infected individual.
Coughing and sneezing: These actions release viral particles into the air, which can then be inhaled by nearby individuals.
Close personal contact: Hugging, kissing, or being in close proximity to an infected person can facilitate the spread.

In environments with a high concentration of people, such as hospitals or public transport, the chances of transmission are increased. Therefore, it is crucial to follow appropriate hygiene measures and avoid contact with those showing respiratory symptoms.

Treatment and Vaccination

Currently, there is no vaccine available for HMPV. The treatment for HMPV is generally supportive and aims at alleviating symptoms. This can include:

Fever reducers like paracetamol
Cough suppressants
Hydration to ease throat irritation and keep mucus thin
Oxygen support for individuals with severe respiratory distress

Since HMPV is a viral infection, antibiotics are not effective. The focus remains on symptom management and monitoring for any escalation in respiratory symptoms. Most individuals recover within 5 to 10 days without needing extensive medical intervention. However, if symptoms worsen, it is vital to seek immediate medical care to prevent complications like pneumonia or bronchiolitis.

Differentiating Between Common Cold and HMPV

Although HMPV causes symptoms very similar to the common cold, there are important differences to note. The first infection with HMPV tends to result in more severe illness, while subsequent infections may present with milder symptoms. It’s important to recognize the following:

Common cold: Typically causes mild symptoms such as a runny nose, mild cough, and sore throat without causing significant breathing issues.
HMPV: May cause more intense symptoms, including fever, shortness of breath, and severe cough, particularly in vulnerable individuals.

Healthcare providers are generally able to distinguish between HMPV and common cold based on the severity of symptoms, medical history, and in some cases, laboratory tests.

Public Reassurance from Health Authorities

Despite the emergence of HMPV cases in Bengaluru, health experts are urging the public not to panic. Dr. Atul Goel, Director-General of Health Services, emphasized that while the virus is circulating, there is no cause for widespread alarm. He reiterated that HMPV is a flu-like virus and is something healthcare professionals are already familiar with. Hospitals are well-prepared for such seasonal outbreaks, and most cases can be managed without hospitalization.

Dr. Ranga Reddy Burri, the President of the Infection Control Academy of India, added that while the virus can lead to severe complications in high-risk groups, fatalities remain rare. He further explained that hospitals have the capacity to handle this type of respiratory virus, and the overall situation does not warrant undue concern.

Preventing HMPV and Respiratory Illnesses

To reduce the risk of contracting HMPV or any other respiratory virus, individuals can follow simple preventive measures:

Hand hygiene: Wash hands frequently with soap and water for at least 20 seconds, especially after being in public places or touching potentially contaminated surfaces. If soap and water are unavailable, use an alcohol-based hand sanitizer.
Cover your cough or sneeze: Use a tissue or the inside of your elbow to cover your mouth and nose when coughing or sneezing to prevent the spread of respiratory droplets.
Wear a mask: Wearing a mask, especially in crowded or enclosed spaces, can significantly reduce the transmission of viruses like HMPV.
Avoid close contact with sick individuals: If someone is showing signs of a respiratory illness, it’s best to avoid close contact with them until they recover.
Self-isolation if symptomatic: If you feel sick, practice self-isolation to prevent infecting others, especially those in vulnerable groups.
Vulnerable groups: Individuals with pre-existing lung conditions, older adults, and young children should be extra cautious and consult with their healthcare provider about additional preventive measures.

Vulnerable Groups and Special Precautions

While HMPV typically causes mild symptoms in healthy individuals, certain groups are at a heightened risk of developing severe illness. These include:

Children under 5 years: Young children, especially infants, are more susceptible to respiratory infections and may require hospitalization for severe symptoms.
Elderly individuals: Older adults, particularly those with underlying health conditions, are more likely to experience complications from respiratory viruses.
Immunocompromised individuals: People with weakened immune systems, such as those undergoing cancer treatment or living with HIV/AIDS, are at a higher risk for severe illness from HMPV.
People with preexisting lung conditions such as asthma or chronic obstructive pulmonary disease (COPD) should be especially cautious during an outbreak of respiratory illnesses.

The detection of two HMPV cases in Bengaluru has brought attention to the ongoing circulation of respiratory viruses worldwide. While HMPV is not new and typically causes mild symptoms, it is important for the public to stay informed about the virus, its symptoms, and prevention methods. Vulnerable individuals must take extra precautions, and everyone should adhere to basic hygiene practices to limit the spread of this and other respiratory infections. By staying vigilant and informed, we can manage the current situation effectively and minimize the impact of HMPV on public health.

HMPV Spreads in India: Gujarat Reports First Case, Third Nationwide After Bengaluru

January 6, 2025, 3:01 pm

Gujarat reported its first case of Human Metapneumovirus (HMPV) on Monday, involving a two-month-old boy from Dungarpur, Rajasthan. The infant is currently in stable condition and being monitored in isolation, according to the Ahmedabad Municipal Corporation. This marks India’s third confirmed HMPV case.

Earlier, two HMPV cases were confirmed in Bengaluru, Karnataka. The first involved a three-month-old girl, who was treated for bronchopneumonia and later discharged, while the second case, detected on January 3, involved an eight-month-old boy, who is stable and recovering.

Both Bengaluru cases had no history of international travel, indicating they were locally acquired and not connected to the HMPV surge in China.

Health authorities are increasing vigilance regarding respiratory illnesses, especially following reports of rising HMPV cases in China. However, the Union Health Ministry has assured the public that there is no cause for panic, emphasizing that robust surveillance systems are in place.

The Health Ministry reassured that HMPV is a known virus, circulating globally, including in India. Surveillance data from ICMR and IDSP has shown no significant increase in Influenza-Like Illness (ILI) or Severe Acute Respiratory Illness (SARI) cases. The ministry is actively monitoring the situation in collaboration with the World Health Organization (WHO). The ICMR has pledged to track HMPV trends year-round and improve laboratory testing capabilities.

HMPV is a common respiratory virus that mainly affects children, the elderly, and individuals with weakened immune systems. While it is not known to cause pandemics, it can sometimes lead to complications in vulnerable groups.

ICMR Flags HMPV Spread In India: What You Should Know To Stay Safe

January 6, 2025, 2:57 pm

The Indian Council of Medical Research (ICMR) has issued an alert regarding the global circulation of Human Metapneumovirus (HMPV), including its presence in India. While Bengaluru recently reported two HMPV cases—an 8-month-old infant recovering and a 3-month-old discharged after treatment—health authorities reassured citizens that the country is well-prepared to manage any potential spike in respiratory illnesses.

The health department confirmed that neither of the infected infants nor their families have a history of recent travel, ruling out international exposure. These cases were detected through routine surveillance for respiratory pathogens.

Monitoring and Surveillance in Progress

The ICMR emphasized that HMPV-related respiratory illnesses have been reported in various countries, but current data from the Integrated Disease Surveillance Programme (IDSP) shows no unusual surge in Influenza-Like Illness (ILI) or Severe Acute Respiratory Illness (SARI) cases in India. The Union Health Ministry and ICMR are actively monitoring the situation through extensive surveillance networks.

In response to rising concerns globally, including a surge in cases in China, the Centre convened a Joint Monitoring Group (JMG) with representatives from the World Health Organization (WHO), National Centre for Disease Control (NCDC), and other health bodies to assess the situation.

State Governments Issue Guidelines

States such as Karnataka, Maharashtra, and Kerala have issued precautionary measures. Kerala’s Health Minister Veena George advised elderly citizens and pregnant women to wear masks but urged the public not to panic.

What Is HMPV?

Discovered in 2001, HMPV belongs to the Pneumoviridae family alongside Respiratory Syncytial Virus (RSV). It spreads through respiratory droplets and direct contact, causing symptoms such as fever, cough, nasal congestion, and shortness of breath. Severe cases can lead to pneumonia or chronic respiratory conditions, especially in young children, the elderly, and individuals with compromised immune systems.

While HMPV poses a potential health concern, India’s health systems remain vigilant, emphasiSing prevention and timely intervention.

Health Body Downplays Concerns Over HMPV Reports from China

January 3, 2025, 10:24 pm

In response to concerns about the spread of HMPV (human metapneumovirus) in China, the Directorate General of Health Services reassured the public that there is “nothing to be alarmed about,” according to Doordarshan.

Atul Goel, Director-General of the health body, clarified that there have been no reported cases of HMPV in India so far. “There has been news about HMPV outbreak in China and that it is serious. We don’t think so, let me be very clear, it is like any other respiratory virus that causes flu-like symptoms mostly in elders and kids aged under 1,” Goel stated.

He emphasized that respiratory illnesses are common during the winter season, and India’s hospitals are well-equipped to handle such cases. “Specifically medicines are not needed because there are not anti-viral drugs against this. There are no major cases, neither in hospitals nor as per ICMR data. There is nothing to be alarmed about,” Goel added.

Earlier, ANI reported that the National Centre for Disease Control (NCDC), under the Union Health Ministry, is actively monitoring seasonal influenza and respiratory cases in India. While the HMPV outbreak in China has not been officially confirmed, the NCDC is reportedly liaising with international health organizations to stay informed.

Health concerns related to respiratory illnesses are common during the winter months in India, especially with the cold wave and poor air quality. Meanwhile, Chinese health authorities recently announced the establishment of a monitoring system to track pneumonia cases of unknown origin, anticipating an increase in respiratory illnesses during winter. This system is aimed at enhancing preparedness to manage emerging pathogens, a lesson learned from the COVID-19 outbreak five years ago.

HMPV in China: Symptoms and Facts About China’s Latest Virus

January 3, 2025, 1:30 pm

What is HMPV, the Mysterious Virus that China is Struggling With?

In recent years, new viruses have emerged with alarming frequency, sparking global health concerns. While the world has been preoccupied with high-profile viruses like COVID-19 and the Ebola outbreak, there is another virus that has been making headlines in China—Human Metapneumovirus (HMPV). Though not as widely recognized as other viral infections, HMPV has been a source of increasing concern, especially in light of its rising cases in various regions, including China.

So, what exactly is HMPV? How does it affect human health, and why is it creating such a stir? In this comprehensive overview, we will explore what HMPV is, its symptoms, how it spreads, why it’s becoming a significant concern, and the efforts being made to control it.

What is Human Metapneumovirus (HMPV)?

Human Metapneumovirus (HMPV) is a respiratory virus that belongs to the Paramyxoviridae family, which is the same family that includes viruses such as the respiratory syncytial virus (RSV) and parainfluenza viruses. HMPV was first identified in 2001 and is considered a relatively new pathogen. It primarily affects the respiratory system, causing infections ranging from mild cold-like symptoms to severe respiratory illness.

HMPV is typically found in humans and can infect individuals of all ages. However, it is most dangerous to vulnerable populations, such as young children, elderly adults, and those with compromised immune systems or underlying health conditions. The virus spreads easily through respiratory droplets when an infected person coughs or sneezes, making it highly contagious, particularly in crowded areas such as households, schools, and healthcare facilities.

Symptoms of HMPV

The symptoms of HMPV are similar to those of other respiratory infections, making it challenging to distinguish from common colds, influenza, or even COVID-19 without a proper diagnostic test. Common symptoms of an HMPV infection include:

Fever: A high fever is a common symptom, especially in the early stages of infection. The fever may last for several days and can be accompanied by chills and fatigue.
Cough: A persistent cough is another hallmark symptom of HMPV. This cough may be dry or productive, and it may worsen over time.
Runny or Stuffy Nose: Much like the common cold, HMPV often causes nasal congestion and a runny nose.
Shortness of Breath: Severe cases of HMPV infection can lead to difficulty breathing, especially in infants, older adults, or those with pre-existing lung conditions.
Wheezing: Wheezing, or a whistling sound when breathing, is common in children and those with compromised lung function.
Sore Throat: A sore throat is another common symptom, similar to other respiratory infections.
Fatigue and Muscle Aches: General malaise, fatigue, and body aches are also often experienced, similar to symptoms of the flu.

In most cases, HMPV causes mild to moderate respiratory illness, but in some individuals—particularly the very young, elderly, or immunocompromised—it can lead to more serious complications, including pneumonia, bronchiolitis, or acute respiratory distress syndrome (ARDS). Hospitalization may be required in severe cases, and in rare instances, the virus can be fatal.

How HMPV Spreads

HMPV spreads primarily through respiratory droplets when an infected person coughs, sneezes, or even talks. The droplets can land on surfaces, and individuals who touch these contaminated surfaces and then touch their face (eyes, nose, or mouth) are at risk of infection. The virus can also be transmitted through close contact with an infected person, such as shaking hands or hugging.

The incubation period for HMPV is typically between 3 and 6 days, and infected individuals can spread the virus even before symptoms appear. This asymptomatic period is one of the reasons why the virus is so difficult to control, as individuals may unknowingly spread it to others.

Why Is HMPV Gaining Attention in China?

In recent months, China has experienced an uptick in HMPV infections, prompting health authorities to closely monitor the virus’s spread. Several factors have contributed to the increasing concern over HMPV in China:

Increasing Case Numbers: Health officials have reported a significant rise in the number of HMPV cases across various regions of China. This increase has drawn attention due to the virus’s potential to cause severe respiratory illness, particularly in vulnerable populations.
Healthcare Strain: China’s healthcare system has been under intense pressure in the wake of the COVID-19 pandemic. Hospitals, already dealing with an overwhelming number of COVID-19 cases, have been facing added strain due to the surge in HMPV cases. The virus’s ability to cause pneumonia and other severe respiratory issues can put a significant burden on hospitals, making it harder for healthcare providers to manage both HMPV and COVID-19 patients.
Complications in Diagnosis: HMPV shares many symptoms with other respiratory infections, making it difficult to diagnose without proper testing. This has led to misdiagnoses or delayed diagnoses, further complicating efforts to control its spread. In some cases, individuals infected with both HMPV and COVID-19 have been identified, leading to more complicated clinical presentations.
Widespread Vulnerability: As mentioned earlier, HMPV is particularly dangerous for vulnerable groups, including young children and the elderly. In a densely populated country like China, where air pollution, respiratory conditions, and crowded living conditions are prevalent, these groups are at higher risk of severe complications from HMPV infection.
Seasonal Variability: Similar to other respiratory viruses like RSV and influenza, HMPV tends to spread more easily in colder months. China is currently experiencing a colder-than-usual winter, which could be facilitating the virus’s transmission, especially in areas with poor ventilation or high population density.

Is HMPV a New Threat?

Although HMPV has been known to science since 2001, it is considered an emerging virus in terms of its threat level. While it has caused outbreaks in the past, it has not garnered the same level of attention as viruses like the flu, RSV, or COVID-19. However, recent studies indicate that HMPV may be more common than previously thought. It may also be more dangerous than once believed, particularly as new strains of the virus evolve.

The ongoing research into HMPV aims to better understand its genetics, its behavior in different populations, and how it evolves over time. Understanding these factors is crucial for public health officials to prepare for future outbreaks and develop effective treatments or vaccines.

Prevention and Treatment of HMPV

At present, there is no specific antiviral treatment for HMPV, and management primarily involves supportive care. In severe cases, individuals may need hospitalization, oxygen therapy, or mechanical ventilation to help with breathing difficulties. Antiviral medications and corticosteroids may be prescribed in some cases to alleviate symptoms and reduce inflammation in the respiratory system.

The most effective ways to prevent HMPV infection are similar to those used to prevent other respiratory infections:

Good Hygiene Practices: Regular handwashing with soap and water is essential to reduce the spread of HMPV. People should avoid touching their face and cover their mouth and nose with a tissue or their elbow when coughing or sneezing.
Avoid Close Contact: Individuals who are sick should avoid close contact with others to prevent spreading the virus. Those who are vulnerable, such as the elderly and young children, should take extra precautions to avoid exposure.
Disinfection of Surfaces: Regularly cleaning and disinfecting high-touch surfaces, such as doorknobs, light switches, and phones, can help reduce the likelihood of surface transmission.
Vaccination Development: There is currently no vaccine for HMPV, but researchers are working on developing one. Vaccines for similar viruses like RSV and influenza have shown promise, and a vaccine for HMPV may be a viable option in the future.

HMPV may not be as well-known as some of its viral counterparts, but it is quickly emerging as a serious public health concern, particularly in regions like China where the virus is currently causing an uptick in cases. Although it generally causes mild symptoms, it can lead to severe respiratory illness, particularly in vulnerable populations.

Given its ability to spread silently and quickly, HMPV requires close monitoring and robust public health efforts to control its spread. While there is no specific treatment for the virus at present, preventive measures such as hygiene practices, avoiding close contact, and disinfecting surfaces are essential for reducing its transmission. As research into the virus continues, there is hope that a vaccine or antiviral treatment may be developed in the future.

Understanding HMPV and its potential impact on global health is crucial, especially as new viruses continue to emerge in a world that is still grappling with the long-term effects of the COVID-19 pandemic.